HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation

TSX-V:HME • CA4236301020

Current stock price

2.885 CAD
+0.04 (+1.58%)
Last:

This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HME.CA Profitability Analysis

1.1 Basic Checks

  • In the past year HME was profitable.
  • HME had a positive operating cash flow in the past year.
  • HME had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HME had a positive operating cash flow.
HME.CA Yearly Net Income VS EBIT VS OCF VS FCFHME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

1.2 Ratios

  • HME's Return On Assets of 23.12% is amongst the best of the industry. HME outperforms 98.03% of its industry peers.
  • HME has a Return On Equity of 34.75%. This is amongst the best in the industry. HME outperforms 98.52% of its industry peers.
  • With an excellent Return On Invested Capital value of 29.46%, HME belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.97%.
Industry RankSector Rank
ROA 23.12%
ROE 34.75%
ROIC 29.46%
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
HME.CA Yearly ROA, ROE, ROICHME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • With an excellent Profit Margin value of 29.84%, HME belongs to the best of the industry, outperforming 94.58% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HME has grown nicely.
  • The Operating Margin of HME (42.20%) is better than 92.61% of its industry peers.
  • HME's Operating Margin has improved in the last couple of years.
  • HME's Gross Margin of 60.69% is fine compared to the rest of the industry. HME outperforms 77.83% of its industry peers.
  • In the last couple of years the Gross Margin of HME has remained more or less at the same level.
Industry RankSector Rank
OM 42.2%
PM (TTM) 29.84%
GM 60.69%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
HME.CA Yearly Profit, Operating, Gross MarginsHME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. HME.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
  • Compared to 1 year ago, HME has less shares outstanding
  • Compared to 5 years ago, HME has more shares outstanding
  • The debt/assets ratio for HME has been reduced compared to a year ago.
HME.CA Yearly Shares OutstandingHME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
HME.CA Yearly Total Debt VS Total AssetsHME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • HME has an Altman-Z score of 6.21. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HME (6.21) is better than 85.22% of its industry peers.
  • HME has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.09, HME belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.03, HME is doing good in the industry, outperforming 76.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 6.21
ROIC/WACC3.67
WACC8.03%
HME.CA Yearly LT Debt VS Equity VS FCFHME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.37, HME is in the better half of the industry, outperforming 69.46% of the companies in the same industry.
  • HME has a Quick Ratio of 1.37. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.37, HME is in the better half of the industry, outperforming 70.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
HME.CA Yearly Current Assets VS Current LiabilitesHME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HME.CA Growth Analysis

3.1 Past

  • The earnings per share for HME have decreased strongly by -15.15% in the last year.
  • The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
  • HME shows a decrease in Revenue. In the last year, the revenue decreased by -6.07%.
  • The Revenue has been growing by 38.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%

3.2 Future

  • The Earnings Per Share is expected to decrease by -16.11% on average over the next years. This is quite bad
  • Based on estimates for the next years, HME will show a decrease in Revenue. The Revenue will decrease by -7.33% on average per year.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HME.CA Yearly Revenue VS EstimatesHME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HME.CA Yearly EPS VS EstimatesHME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. HME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.30 indicates a reasonable valuation of HME.
  • Based on the Price/Earnings ratio, HME is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.
  • HME is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 11.20, the valuation of HME can be described as reasonable.
  • HME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 74.38% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. HME is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.3
Fwd PE 11.2
HME.CA Price Earnings VS Forward Price EarningsHME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HME is valued cheaper than 90.64% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HME is valued cheaply inside the industry as 91.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.53
EV/EBITDA 4.99
HME.CA Per share dataHME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The excellent profitability rating of HME may justify a higher PE ratio.
  • A cheap valuation may be justified as HME's earnings are expected to decrease with -16.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HME.CA Dividend Analysis

5.1 Amount

  • HME has a Yearly Dividend Yield of 3.50%.
  • Compared to an average industry Dividend Yield of 3.03, HME pays a bit more dividend than its industry peers.
  • HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.5%

5.2 History

  • HME has been paying a dividend for over 5 years, so it has already some track record.
  • HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
HME.CA Yearly Dividends per shareHME.CA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 54.76% of the earnings are spent on dividend by HME. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Yearly Income VS Free CF VS DividendHME.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M
HME.CA Dividend Payout.HME.CA Dividend Payout, showing the Payout Ratio.HME.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HME.CA Fundamentals: All Metrics, Ratios and Statistics

HEMISPHERE ENERGY CORP

TSX-V:HME (4/27/2026, 7:00:00 PM)

2.885

+0.04 (+1.58%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-15
Earnings (Next)05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap272.06M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (2.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.5%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-7.92%
Valuation
Industry RankSector Rank
PE 10.3
Fwd PE 11.2
P/S 2.9
P/FCF 8.53
P/OCF 5.65
P/B 3.38
P/tB 3.38
EV/EBITDA 4.99
EPS(TTM)0.28
EY9.71%
EPS(NY)0.26
Fwd EY8.93%
FCF(TTM)0.34
FCFY11.73%
OCF(TTM)0.51
OCFY17.7%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-19.57%)
Profitability
Industry RankSector Rank
ROA 23.12%
ROE 34.75%
ROCE 39.28%
ROIC 29.46%
ROICexc 36.52%
ROICexgc 36.52%
OM 42.2%
PM (TTM) 29.84%
GM 60.69%
FCFM 33.99%
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.04
Cap/Depr 140.25%
Cap/Sales 17.31%
Interest Coverage 250
Cash Conversion 94.07%
Profit Quality 113.94%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 6.21
F-Score6
WACC8.03%
ROIC/WACC3.67
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%

HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.


What is the valuation status for HME stock?

ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.


What is the profitability of HME stock?

HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.


Can you provide the financial health for HME stock?

The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.


What is the earnings growth outlook for HEMISPHERE ENERGY CORP?

The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.